EOD Primary Tumor

This input is used for staging

Default

999

NAACCR Item

NAACCR #772

Code	Description	SS2018 T
000	Non-invasive papillary carcinoma	IS
050	Carcinoma in situ	IS
100	Subepithelial connective tissue (lamina propria, submucosa) invaded Localized, NOS	L
200	Muscularis involved	L
300	Corpus spongiosum Periurethral muscle (sphincter muscle)	RE
400	Bladder neck Corpus cavernosum Vagina (anterior, NOS)	RE
700	Adjacent organ(s), NOS Bladder wall Further contiguous extension	D
800	No evidence of primary tumor	U
999	Unknown; extension not stated Primary tumor cannot be assessed Not documented in patient record Death Certificate Only	U

(1) Fritz AG, Ries LAG (eds). **SEER Extent of Disease 1988: Codes and Coding Instructions (3rd Edition, 1998)**, National Cancer Institute, NIH Pub. No. 98-2313, Bethesda, MD, 1998 (2) Young JL Jr, Roffers SD, Ries LAG, Fritz AG, Hurlbut AA (eds.). **SEER Summary Staging Manual-2000: Codes and Coding Instructions**, National Cancer Institute, NIH Pub. No. 01-4969, Bethesda, MD, 2001. (3) Collaborative Stage Work Group of the American Joint Committee on Cancer. **Collaborative Stage Data Collection System User Documentation and Coding Instructions, version 02.05**. American Joint Committee on Cancer (Chicago, IL) (4) Gress, D.M., Edge, S.B., Gershenwald, J.E., et al. **Principles of Cancer Staging**. In: Amin, M.B., Edge, S.B., Greene, F.L., et al. (Eds.) AJCC Cancer Staging Manual. 8th Ed. New York: Springer; 2017: 3-30 (5) Hansel, D.E., Reuter, V.E., McKiernan, J.M., et al. **Urethra**. In: Amin, M.B., Edge, S.B., Greene, F.L., et al. (Eds.) AJCC Cancer Staging Manual. 8th Ed. New York: Springer; 2017: 767-776